Concepedia

Author

Tenjin Nishikura

Showa UniversityORCID

Also Known As

T N Nishikura, T Nishikura, Tenjin NISHIKURA, Tenjin Nishikura

34

Publications

424

Citations

6

H-Index

8

Concepts

All Affiliations

Showa UniversityJapanese Red Cross Society Wakayama Medical CenterKokura Memorial HospitalJuntendo University Shizuoka HospitalShowa University Fujigaoka Hospital
TN

About

Tenjin Nishikura is an author at Showa University specializing in urology, chronic kidney disease, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

10

2

Nephrology

1

1

10

3

Hemodialysis

1

1

10

4

Percutaneous Coronary Intervention

1

1

10

5

Atherosclerosis

1

1

10

Tenjin Nishikura

×

6

Publications

402

Citations

6

H-Index

YearCitations

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki,

JAMA Cardiology

2022

275

Elevated Small Dense Low-Density Lipoprotein Cholesterol as a Predictor for Future Cardiovascular Events in Patients with Stable Coronary Artery Disease

Tenjin Nishikura, Shinji Koba, Yuya Yokota,

Journal of Atherosclerosis and Thrombosis

2014

83

Prevalence and Effects of High-Intensity Statins for Japanese Patients Presenting With Acute Coronary Syndrome　― A Post Hoc Secondary Analysis of STOPDAPT-2 ACS ―

Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto,

Circulation Journal

2022

13

Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention

Ko Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto,

JACC: Cardiovascular Interventions

2022

11

Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis

Hiroaki Tsujita, Yuji Hamazaki, Tenjin Nishikura,

Cardiovascular Intervention and Therapeutics

2012

10

Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial

Yuki Obayashi, Masahiro Natsuaki, Hirotoshi Watanabe,

European Heart Journal - Cardiovascular Pharmacotherapy

2024

10

Page 1